Neoindicate
Wellington, US · 1 known investors
Find your way into Neoindicate
Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.
Investors · 1
Frequently asked questions
- What does Neoindicate do?
- Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.
- Who are Neoindicate's investors?
- Neoindicate's investors include CWRU Technology Ventures.
- Where is Neoindicate headquartered?
- Neoindicate is headquartered in Wellington, US.